A detailed history of Solstein Capital, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Solstein Capital, LLC holds 133 shares of BSX stock, worth $13,657. This represents 0.0% of its overall portfolio holdings.

Number of Shares
133
Previous 362 63.26%
Holding current value
$13,657
Previous $38,000 68.42%
% of portfolio
0.0%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025

SELL
$97.03 - $108.14 $22,219 - $24,764
-229 Reduced 63.26%
133 $12,000
Q2 2025

Jul 31, 2025

BUY
$89.7 - $107.41 $32,471 - $38,882
362 New
362 $38,000
Q2 2020

Aug 12, 2020

SELL
$30.19 - $39.11 $8,121 - $10,520
-269 Closed
0 $0
Q1 2020

May 12, 2020

BUY
$25.83 - $45.71 $929 - $1,645
36 Added 15.45%
269 $9,000
Q4 2019

Feb 12, 2020

BUY
$37.87 - $45.37 $8,823 - $10,571
233 New
233 $11,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $147B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Solstein Capital, LLC Portfolio

Follow Solstein Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Solstein Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Solstein Capital, LLC with notifications on news.